(Q46176776)

English

Naftopidil versus tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia with special reference to the storage symptom: a prospective randomized controlled study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19120513

Naftopidil versus tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia with special reference to the storage symptom: a prospective randomized controlled study (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19120513

prostatic hypertrophy

1 reference

based on heuristic

inferred from title

1

object named as

Osamu Ukimura

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19120513

author name string

Motohiro Kanazawa

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19120513

Atsuko Fujihara

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19120513

Kazumi Kamoi

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19120513

Koji Okihara

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19120513

Tsuneharu Miki

6

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19120513

Kyoto Prefectural University of Medicine Benign Prostatic Hypertrophy Research Group

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19120513

publication date

1 December 2008

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19120513

International Journal of Urology

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19120513

15

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19120513

12

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19120513

1049-1054

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19120513

Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02169.X

21 January 2018

Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02169.X

21 January 2018

Clinical efficacy of an alpha1A/D-adrenoceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02169.X

21 January 2018

Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02169.X

21 January 2018

Alpha1-adrenergic receptors in human spinal cord: specific localized expression of mRNA encoding alpha1-adrenergic receptor subtypes at four distinct levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02169.X

21 January 2018

Potential mechanisms of action of superselective alpha(1)-adrenoceptor antagonists

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02169.X

21 January 2018

Increased contractile response to phenylephrine in detrusor of patients with bladder outlet obstruction: effect of the alpha1A and alpha1D-adrenergic receptor antagonist tamsulosin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02169.X

21 January 2018

Effects of intrathecal injection of tamsulosin and naftopidil, alpha-1A and -1D adrenergic receptor antagonists, on bladder activity in rats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02169.X

21 January 2018

Comparison of tamsulosin and naftopidil for efficacy and safety in the treatment of benign prostatic hyperplasia: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02169.X

21 January 2018

Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02169.X

21 January 2018

Quantification and distribution of alpha 1-adrenoceptor subtype mRNAs in human prostate: comparison of benign hypertrophied tissue and non-hypertrophied tissue

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02169.X

21 January 2018

Pharmacologic perspective on the physiology of the lower urinary tract

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02169.X

21 January 2018

Improvement of bladder storage function by alpha1-blocker depends on the suppression of C-fiber afferent activity in rats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02169.X

21 January 2018

Activation of alpha1D adrenergic receptors in the rat urothelium facilitates the micturition reflex

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02169.X

21 January 2018

AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02169.X

21 January 2018

Usefulness of tamsulosin hydrochloride and naftopidil in patients with urinary disturbances caused by benign prostatic hyperplasia: a comparative, randomized, two-drug crossover study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02169.X

21 January 2018

Identifiers

10.1111/J.1442-2042.2008.02169.X

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19120513

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19120513

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46176776&oldid=2098464898"